O1jective-To characterise the effect of interleukin-4 (IL-4) on the biosynthesis of cyclo-oxygenases I (COX I) and II (COX H), the rate limiting enzymes of the synthesis ofprostaglandin E2 (PGE2), in freshly prepared rheumatoid synovial cells. Methods-Adherent synovial celis were obtained from rheumatoid synovium by collagenase digestion. The concentrations of PGE2 in culture supernatants were determined by enzyme linked immunosorbent assay. The protein and mRNA concentrations of COX I and COX II were determined by Western blotting and reverse transcription polymerase chain reaction, respectively. Results-Freshly prepared synovial cells produced large amounts of PGE2. They also showed increased gene expression of COX I and COX II, and synthesised these proteins. IL-4 had suppressive effects on the production of PGE2 by untreated or lipopolysaccharide (LPS) stimulated synovial celis. In addition, IL-4 inhibited the biosynthesis of COX II at the mRNA level. In contrast, it did not modify the protein concentration of COX I. In tests of cell specificity, IL-4 did not reduce the mRNA concentration of COX II in interleukin-la (IL-la) stimulated cultured synovial fibroblasts at passages 3-6, but it reduced considerably the mRNA concentrations of COX II in an LPS or IL-la stimulated U937 monocyte/macrophage cell line. Conclusions-These results suggest that IL-4 might inhibit overproduction of PGE2 in rheumatoid synovia via selective inhibition of the biosynthesis of COX II, and that this inhibition might be specific to macrophage-like synovial celis.
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(Ann Rheum Dis 1996; 55: [375] [376] [377] [378] [379] [380] [381] [382] Rheumatoid arthritis (RA) is an inflammatory joint disease in which perpetuation of the chronic synovitis leads to bone and cartilage degradation.' Inflammatory cytokines or soluble factors are essential in pathogenesis of RA, and rheumatoid synovia are known to be rich sources of these mediators.' 2 Among them, prostaglandin E2 (PGE2), actively produced by rheumatoid synovia, is widely considered to have an important role in the inflammatory process in rheumatoid joints.3'4 Consequently, nonsteroidal anti-inflammatory drugs (NSAIDs), the inhibitors of the production of prostaglandin metabolites, are extensively used in the treatment of RA.
Cyclo-oxygenase (COX), which converts arachidonic acid to prostaglandin endoperoxides, is the rate limiting enzyme in prostanoid synthesis.5 At least two forms of COX have been identified, and their genes have been cloned:6 type I COX (COX I) is expressed constitutively in most tissues and is involved in cellular 'housekeeping' activities such as coordinating actions of circulating hormones and regulating vascular homeostasis. 7 In contrast, type II COX (COX II) is highly inducible by serum, growth factors, and lipopolysaccharide (LPS) in certain cell types involved in the inflammatory process in RA, including macrophages,8 fibroblasts,9 10 and endothelial cells." In addition, it has been demonstrated that COX II is expressed in rheumatoid synovia and synovial fibroblasts, and that interleukin-l1 (IL-1i) increases the mRNA concentrations of COX II in these cells.'2 13 These observations suggest that COX II may play an important part in overproduction of PGE2 in rheumatoid synovia.
Interleukin-4 (IL-4), originally described as a B cell growth factor, is a 20 kDa product of activated T cells. '4 We and other investigators previously reported that IL-4 inhibited the production of inflammatory cytokines such as IL-1i3, IL-6, and IL-8 by rheumatoid synovia or freshly prepared rheumatoid synovial cells.'5-'" In addition to these anti-inflammatory actions, inhibitory effects of IL-4 on PGE2 production by monocytes/macrophages,'1520 fibroblasts,'0 and mesangial cells2' have also been demonstrated. However, the mechanism(s) of the inhibitory action of IL-4 on PGE2 production remains to be clarified.
We have investigated the effect of IL-4 on the production of PGE2, and on the biosynthesis First Department of Internal Medicine, Toyama Medical and and gene expression of COX I and COX II, in freshly prepared rheumatoid synovial cells.
Patients and methods

PATIENT POPULATION
Rheumatoid synovial tissues were obtained from the knee or wrist joints of patients who were undergoing surgical synovectomy or total joint replacement. The population consisted of five patients with RA (three women and two men, age range 52-63 years) who fulfilled the criteria of the American College of Rheumatology. 22 All five patients were treated with NSAIDs; two of the five were treated with gold sodium thiomalate, and another two with bucillamine.
CELL CULTURE
Adherent rheumatoid synovial cells-Isolated rheumatoid synovia were aseptically dissected free from surrounding tissues, minced, and enzymatically digested with 0 5-1 mg/ml clostridium collagenase (Wako Pure Chemical Industries, Ltd, Osaka, Japan) and 5-10 gg/ml deoxyribonuclease 1 (Sigma Chemical Co St Louis, MO) for two to three hours. After digestion, the resultant single cell suspension was washed, filtered through sterile gauze and nylon mesh, washed thoroughly once again, and finally resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat inactivated fetal calf serum (FCS) (ICN Biomedicals, Australia), penicillin 100 U/ml, gentamicin 60 ,ug/ml, N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid (HEPES) 12X5 mmol/l, and L-glutamine 2 mmoIl (DMEM/ 10% FCS). The PGE2 in the culture supernatant was measured using a commercially available enzyme linked immunosorbent assay kit according to the manufacturer's instructions (ELISA Technology, Lexington, KY).
WESTERN BLOT ANALYSIS
After incubation with various stimuli, freshly prepared adherent synovial cells were lysed in a buffer (50 mmol/l TRIS hydrochloric acid, pH 8-0, 1% Nonidet® P-40, 0 5% deoxycholic acid, 150 mmol/l sodium chloride, and 1 mmol/l phenyl methylsulphonyl fluoride). Proteins were separated by electrophoresis on a 7.5% sodium dodecyl sulphate-polyacrylamide gel, and transferred onto an Immobilon-P membrane (Millipore, Bedford, MA). After blocking, the membrane was incubated with antihuman COX I or antihuman COX II rabbit polyclonal antibodies (Oxford Biomedical Research, Oxford, MI), then with antirabbit donkey antibodies conjugated with horseradish peroxidase. Specific bands were visualised by an enhanced chemiluminescence detection system (ECL, Amersham International, Buckinghamshire, UK), and exposed to Fuji new RX films (Fuji Photo Film, Kanagawa, Japan).
EXTRACTION OF RNA, AND REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR)
Freshly prepared adherent synovial cells, rheumatoid synovial fibroblasts, or PMA differentiated U937 cells were cultured with IL-lot or LPS in the presence or absence of IL-4, dexamethasone, or indomethacin for eight hours, and their total cellular RNAs were extracted by acid guanidine phenol/chloroform extraction24 using Isogen (Wako Pure Chemical Industries, Ltd).
Two micrograms of total RNA was reverse transcribed to cDNA after annealing with 100 pmol of oligo deoxythymine (dT)12 18 25 pmol ofrandom primer (Takara Shuzo Co Ltd, Kyoto, Japan), and 10 pmol of each deoxynucleotide (Takara Shuzo Co) in a total volume of 10 RIl for one hour at 37°C. Two microlitres of the resultant cDNA preparation was used directly for each amplification reaction.
The polymerase chain reaction (PCR) was performed in a 50 jil reaction mixture containing 20 pmol of each primer (see below), 20 pmol of each deoxynucleotide and 1-25 U Taq DNA polymerase (Takara Shuzo Co Ltd). Amplification of each specific PCR product was carried out separately, in a different tube. Primers used were: COX I sense primer, 5'-GA-GGGGCAGGAAAGCAGCAT-3' (nucleotide 1804-1823'); COX I antisense primer, 5'-CA-TCAGCCAGGGAACACAAC-3' (nucleotide 2210'-2229'); COX II sense primer, 5'-GA-AACCCACTCCAAACACAG-3' (nucleotide 298-317); COX II antisense primer, 5'-CG-TAGATGCTCAGGGACTTG-3' (nucleotide 887-906'); hypoxanthine phosphoribosyl transferase (HPRT) sense primer, 5'-CTCCGCC-TCCTCCTCTGCTC-3' (nucleotide 12-31'); HPRT antisense primer, 5'-TTGCGACCT-TGACCATCI-r--3' (nucleotide 550'-569'); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense primer, 5'-CAAAAGGGT-CATCATCTCTG-3' (nucleotide 408'-427'); GAPDH antisense primer, 5 After incubation, the cells were lysed and the lysates analysed by western blotting using rabbit antihuman COX I and COX II. Adherent synovial cells were also cultured with LPS 1 ,ug/ml in the presence or absence of IL-4 1, 10, 100, or 1000 U/ml for 24 hours and the protein level of COX II in the cell lysate determined by western blotting. 24 well macroplates with or without IL-la 10 ng/ml in the presence of IL-4 100 U/ml, dexamethasone 5 pmoVl, or indomethacin 5 prmol/l for 24 hours and the concentrations of PGE2 in the culture supernatants determined. Additional cells were cultured with or without IL-la 10 ng/ml in the presence of IL-4 10 or 100 U/ml (experiment S7glSgVamia (fig 2A) . This effect was consistently observed in patients with RA: a mean (SD) inhibition of 56 (3)% was observed in the five patients studied (fig 3) .
LPS markedly enhanced the production of PGE, by these cells, and IL-4 inhibited this augmented production in a dose dependent manner ( fig 2B) . However, the effect of IL-4 seemed to be less potent than that of either dexamethasone or indomethacin. (fig 4A) . This inhibition of Unexpectedly, IL-4 did not inhibit PGE, COX II biosynthesis by IL-4 was dose production by IL-l a( stimulated rheumatoid dependent and was effective at concentrations synovial fibroblasts (fig 6A) , but dexameas small as 10 U/ml ( fig 4B) . IL-4 also reduced thasone and indomethacin each had a potent the remarkably increased protein content of inhibitory effect on its production. IL-4 also COX II observed when the adherent synovial failed to alter the content of COX II mRNA cells were incubated in the presence of IL-lac in these cells (fig 6B) . or LPS (fig 4A) . In contrast, IL-4, LPS, or When PGE, production and the gene expression of COX II by the PMA differ- LPS for eight hours, and IL-4 strongly inhibited the enhanced levels of COX II mRNA, as did dexamethasone ( fig 7B) . Discussion PGE2 is a potent mediator of the pain and oedema associated with rheumatoid synovitis, and is involved in bone resorption.3 In the present study, freshly prepared adherent synovial cells spontaneously produced large amounts of PGE2. However, the capacity of these cells to produce PGE2 was rapidly lost during the period of culture, suggesting that these cells maintained the nature of the inflammatory process that was seen in the patient. Consequently, use of freshly prepared adherent synovial cells was appropriate in this study, though these cells were heterogeneous.
We were able to demonstrate that the protein and mRNA contents of COX II were spontaneously expressed in freshly prepared adherent synovial cells, and that IL-lot and LPS increased their protein contents. In contrast, these stimuli did not modify the protein contents of the constitutive COX I. These results are consistent with those of previous studies showing that the mRNA level of COX II was upregulated by IL-13 in cultured synovial cells from patients with RA12 or osteoarthritis,26 and suggest that overproduction of PGE2 in rheumatoid synovia might be mainly attributable to new synthesis of COX II enzyme in response to various stimuli including IL-1.
We and other investigators have previously demonstrated the anti-inflammatory effects of IL-4 on rheumatoid synovia or synovial cells by inhibiting the production of proinflammatory cytokines such as IL-1,, IL-6, and IL-8. [15] [16] [17] We have now shown that IL-4 inhibited the spontaneous production of PGE2 by 56%, and that these suppressive effects were also observed in adherent synovial cells stimulated by LPS or IL-lIx. In addition, IL-4 inhibited the protein and mRNA contents of COX II, but did not modify those of COX I. This is the first report of the effect of IL-4 on the expression of COX in rheumatoid synovia, while decreased concentrations of IL-4 in rheumatoid synovia have been reported at the protein27 and mRNA levels.28 Together, these findings suggest that a lack of IL-4 might be partially involved in the overexpression of COX II in the rheumatoid synovium.
The mechanism(s) by which IL-4 selectively inhibits the production of COX II mRNA are unknown, though one recent study demonstrated that IL-4 inhibited COX II mRNA at both the level of transcription and that of posttranscription.29 The human COX I and II polypeptides are 61% identical in primary Figure 7 Effect of interleukin-4 (IL-4) on production ofprostaglandin E2 (PGE) and gene expression ofcyclo-oxygenase II (COX II) by a phorbol myristate acetate differentiated U937 macrophage cell line stimulated with interleukin-lot (IL-Ia) 10 
